SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-146421
Filing Date
2021-12-03
Accepted
2021-12-03 17:13:33
Documents
1
Period of Report
2021-12-02

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2134552-4_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2134552-4_4seq1.xml 4 4244
  Complete submission text file 0001104659-21-146421.txt   5939
Mailing Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036
Business Address 7 TIMES SQUARE SUITE 2503 NEW YORK NY 10036 6462005278
SELLAS Life Sciences Group, Inc. (Issuer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 16760 SW UPPER BOONES FERRY RD SUITE 101 PORTLAND X1 97224
Business Address
Burns John Thomas (Reporting) CIK: 0001568734 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 211471095